Search research articles
Contact Us
Filters
Showing results (31-40 of 45) with videos related to
Page
of 5
Sort By:
Thrombosis and Haemostasis
|
January 23, 1992
Prevention of hepatitis C virus infection in children with haemophilia A and B and von Willebrand's disease
W Kreuz, G Auerswald, C Brückmann, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
May 24, 2016
Immune tolerance therapy in paediatric haemophiliacs with factor VIII inhibitors: 14 years follow-up
W Kreuz, S Ehrenforth, M Funk, et al.
The New England Journal of Medicine
|
April 9, 1987
Absence of hepatitis after treatment with a pasteurized factor VIII concentrate in patients with hemophilia and no previous transfusions
K Schimpf, P M Mannucci, W Kreutz, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
February 8, 2013
Novel coagulation factor concentrates: issues relating to their clinical implementation and pharmacokinetic assessment for optimal prophylaxis in haemophilia patients
R Ljung, G Auerswald, G Benson, et al.
The New England Journal of Medicine
|
October 26, 1989
Absence of anti-human immunodeficiency virus types 1 and 2 seroconversion after the treatment of hemophilia A or von Willebrand's disease with pasteurized factor VIII concentrate
K Schimpf, H H Brackmann, W Kreuz, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
September 11, 2004
Continuous infusion of B-domain deleted recombinant factor VIII (ReFacto) in patients with haemophilia A undergoing surgery: clinical experience
N Stieltjes, C Altisent, G Auerswald, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
January 11, 2007
Evaluation of pharmacokinetics, efficacy and safety of Immunate solvent detergent in previously treated patients with severe haemophilia A
L Nemes, T Lissitchkov, A Klukowska, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
February 28, 2004
Health status and health-related quality of life of children with haemophilia from six West European countries
A Gringeri, S von Mackensen, G Auerswald, et al.
Acta Haematologica
|
February 29, 2008
Pharmacokinetics, efficacy and safety of IMMUNATE solvent/detergent (IMMUNATE S/D) in previously treated patients with severe hemophilia A: results of a prospective, multicenter, open-label phase III study
L Nemes, T Lissitchkov, G Dobaczewski, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
September 21, 2007
Prophylactic treatment of haemophilia patients with inhibitors: clinical experience with recombinant factor VIIa in European Haemophilia Centres
M Morfini, G Auerswald, R A Kobelt, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 45) with videos related to
Sort By:
Page
of 5
Thrombosis and Haemostasis
|
January 23, 1992
Prevention of hepatitis C virus infection in children with haemophilia A and B and von Willebrand's disease
W Kreuz, G Auerswald, C Brückmann, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
May 24, 2016
Immune tolerance therapy in paediatric haemophiliacs with factor VIII inhibitors: 14 years follow-up
W Kreuz, S Ehrenforth, M Funk, et al.
The New England Journal of Medicine
|
April 9, 1987
Absence of hepatitis after treatment with a pasteurized factor VIII concentrate in patients with hemophilia and no previous transfusions
K Schimpf, P M Mannucci, W Kreutz, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
February 8, 2013
Novel coagulation factor concentrates: issues relating to their clinical implementation and pharmacokinetic assessment for optimal prophylaxis in haemophilia patients
R Ljung, G Auerswald, G Benson, et al.
The New England Journal of Medicine
|
October 26, 1989
Absence of anti-human immunodeficiency virus types 1 and 2 seroconversion after the treatment of hemophilia A or von Willebrand's disease with pasteurized factor VIII concentrate
K Schimpf, H H Brackmann, W Kreuz, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
September 11, 2004
Continuous infusion of B-domain deleted recombinant factor VIII (ReFacto) in patients with haemophilia A undergoing surgery: clinical experience
N Stieltjes, C Altisent, G Auerswald, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
January 11, 2007
Evaluation of pharmacokinetics, efficacy and safety of Immunate solvent detergent in previously treated patients with severe haemophilia A
L Nemes, T Lissitchkov, A Klukowska, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
February 28, 2004
Health status and health-related quality of life of children with haemophilia from six West European countries
A Gringeri, S von Mackensen, G Auerswald, et al.
Acta Haematologica
|
February 29, 2008
Pharmacokinetics, efficacy and safety of IMMUNATE solvent/detergent (IMMUNATE S/D) in previously treated patients with severe hemophilia A: results of a prospective, multicenter, open-label phase III study
L Nemes, T Lissitchkov, G Dobaczewski, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
September 21, 2007
Prophylactic treatment of haemophilia patients with inhibitors: clinical experience with recombinant factor VIIa in European Haemophilia Centres
M Morfini, G Auerswald, R A Kobelt, et al.
Page
of 5